DD209810A5 - Verfahren zur herstellung von a-21978c-cyclopeptidderivaten - Google Patents

Verfahren zur herstellung von a-21978c-cyclopeptidderivaten Download PDF

Info

Publication number
DD209810A5
DD209810A5 DD83251131A DD25113183A DD209810A5 DD 209810 A5 DD209810 A5 DD 209810A5 DD 83251131 A DD83251131 A DD 83251131A DD 25113183 A DD25113183 A DD 25113183A DD 209810 A5 DD209810 A5 DD 209810A5
Authority
DD
German Democratic Republic
Prior art keywords
salts
formula
compounds
deep
hydrogen
Prior art date
Application number
DD83251131A
Other languages
German (de)
English (en)
Inventor
Manuel Debono
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD209810A5 publication Critical patent/DD209810A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62Streptosporangium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD83251131A 1982-05-21 1983-05-20 Verfahren zur herstellung von a-21978c-cyclopeptidderivaten DD209810A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,498 US4399067A (en) 1982-05-21 1982-05-21 Derivatives of A-21978C cyclic peptides

Publications (1)

Publication Number Publication Date
DD209810A5 true DD209810A5 (de) 1984-05-23

Family

ID=23501401

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83251131A DD209810A5 (de) 1982-05-21 1983-05-20 Verfahren zur herstellung von a-21978c-cyclopeptidderivaten

Country Status (15)

Country Link
US (1) US4399067A (enExample)
KR (1) KR860002185B1 (enExample)
AT (1) AT380022B (enExample)
CA (1) CA1215043A (enExample)
DD (1) DD209810A5 (enExample)
DK (1) DK220983A (enExample)
EG (1) EG16042A (enExample)
ES (1) ES522561A0 (enExample)
FI (1) FI831746L (enExample)
GR (1) GR79259B (enExample)
HU (1) HU192955B (enExample)
PH (1) PH21382A (enExample)
PL (1) PL242096A1 (enExample)
PT (1) PT76701B (enExample)
RO (1) RO86721B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US5140101A (en) * 1990-11-21 1992-08-18 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
US5256548A (en) * 1990-11-21 1993-10-26 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
WO2001044271A2 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6911525B2 (en) * 1999-12-15 2005-06-28 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
EP1423137B1 (en) * 2001-08-06 2009-04-29 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
RU2512396C2 (ru) * 2008-12-22 2014-04-10 Кьюбист Фармасьютикалз, Инк. Новые противобактериальные средства для лечения грамположительных инфекций
AR074874A1 (es) * 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
US4208403A (en) * 1978-10-16 1980-06-17 Eli Lilly And Company A-21978 Antibiotics and process for their production
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus

Also Published As

Publication number Publication date
KR860002185B1 (ko) 1986-12-24
ES8407012A1 (es) 1984-09-01
DK220983A (da) 1983-11-22
ES522561A0 (es) 1984-09-01
PT76701B (en) 1986-03-27
ATA178383A (de) 1985-08-15
CA1215043A (en) 1986-12-09
FI831746A7 (fi) 1983-11-22
RO86721A (ro) 1985-04-17
HU192955B (en) 1987-08-28
EG16042A (en) 1986-12-30
US4399067A (en) 1983-08-16
PT76701A (en) 1983-06-01
PH21382A (en) 1987-10-15
AT380022B (de) 1986-03-25
GR79259B (enExample) 1984-10-22
RO86721B (ro) 1985-05-01
KR840005076A (ko) 1984-11-03
FI831746L (fi) 1983-11-22
FI831746A0 (fi) 1983-05-18
PL242096A1 (en) 1984-07-02
DK220983D0 (da) 1983-05-18

Similar Documents

Publication Publication Date Title
DE69122432T2 (de) Zyklisches Polypeptid mit antibiotischer Aktivität, dessen Herstellung und Reinkultur eines Coelomycetes Stammes
US4482487A (en) A-21978C cyclic peptides
DD209810A5 (de) Verfahren zur herstellung von a-21978c-cyclopeptidderivaten
USRE32311E (en) Derivatives of A-21978C cyclic peptides
USRE32310E (en) Derivatives of A-21978C cyclic peptides
US4320052A (en) Derivatives of A-30912A nucleus
DD146618A5 (de) Verfahren zur herstellung des antibiotikums
KR0139628B1 (ko) 항생물질 머사시딘, 이의 제조방법 및 이를 함유하는 약제
US4293491A (en) Derivatives of A-30912H nucleus
EP0095295B1 (en) Cyclic peptide derivatives
EP0031221A1 (en) Cyclic peptide nuclei
EP0916680B1 (de) Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung desselben
EP0032009A1 (en) Derivatives of cyclic peptide nuclei
US4293488A (en) Derivatives of A-30912B nucleus
DD155178A5 (de) Verfahren zur herstellung von derivaten cyclischer peptidkerne
DD210258A5 (de) Verfahren zur herstellung von a-21978c-cyclopeptidderivaten
DE60110908T2 (de) Antibiotische tripropeptine und verfahren ihrer herstellung
US4293487A (en) Derivatives of A-30912D nucleus
DE68925540T2 (de) Peptid-Antibiotika
EP0005956A1 (en) A-38533 antibiotics, their preparation, formulations containing them, and micro-organism employed in their production
DE68912355T2 (de) Antibiotische Antitumor-Verbindung und Methode zu deren Herstellung.
EP0031220A1 (en) Derivatives of cyclic peptide nuclei
DE69709802T2 (de) Amythiamicin Amid-Derivate
DE3887292T2 (de) Antibiotische Verbindungen, genannt A/16686-Faktoren A'1,A'2 und A'3.
DD210257A5 (de) Verfahren zur herstellung von a-21978c-cyclopeptidderivaten